-
August 31, 2012
Although this has been a solid year for med-tech, some sub-sectors are starting to lag a bit during this late summer ...
-
August 30, 2012
Idenix Pharmaceuticals, Inc. (IDIX) recently received a verbal notice from the US Food and Drug Administration (FDA) ...
-
August 29, 2012
Gilead Sciences, Inc. (GILD) recently gained US Food and Drug Administration (FDA) approval for its HIV combination ...
-
August 29, 2012
AstraZeneca (AZN) recently announced that Pascal Soriot has been recruited as the new Chief Executive Officer (CEO) ...
-
August 29, 2012
Par Pharmaceuticals Companies Inc. (PRX) recently announced that the "go shop" period under the terms of the earlier ...
-
August 28, 2012
Synergy Pharmaceuticals Inc. (SGYP) recently acquired all assets related to FV-100, an oral nucleoside analogue, ...
-
August 27, 2012
Bristol-Myers Squibb Company (BMY) recently suffered a pipeline setback when it announced the discontinuation of the ...
-
August 27, 2012
Here are some events happening this week that will impact the medical technology sector. Although this has been a ...
-
August 20, 2012
Idenix Pharmaceuticals, Inc. (IDIX) recently suffered a huge setback when it received a verbal notice from the US ...
-
August 14, 2012
Eli Lilly and Company (LLY) recently updated its reported (GAAP) guidance for 2012 following the early payment of ...
-
August 13, 2012
Simcere Pharmaceutical Group's (SCR) second quarter 2012 earnings of 8 cents per American Depositary Share (ADS), a ...
-
August 03, 2012
Bristol-Myers Squibb Company (BMY) recently suffered a pipeline setback when it voluntarily decided to halt a phase ...
-
August 02, 2012
It's been a bad day for the market after the morning's trading. The Nasdaq has fallen 0.4%; the S&P 500 has declined ...
-
July 27, 2012
MoneyShow's Tom Aspray takes an in-depth look at his successful Charts in Play Portfolio, as he looks to take ...
-
July 27, 2012
Sanofi (SNY) reported second quarter 2012 business earnings of 95 cents per American Depository Share (ADS), much ...
-
July 25, 2012
Bristol-Myers Squibb Company (NYSE:BMY) announced its results for the second quarter on July 25, 2012. Bristol-Myers ...
-
July 23, 2012
The US Food and Drug Administration (FDA) recently approved Gilead Sciences, Inc.'s (GILD) once-daily oral Truvada ...
-
July 23, 2012
Biopharmaceutical giant Bristol-Myers Squibb Company (BMY) is all set to unveil its second quarter 2012 results ...
-
July 23, 2012
Analysts are expecting a drop in profit for Bristol-Myers Squibb (NYSE:BMY) when it reports its results for the ...
-
July 19, 2012
Yet another generic version of Pfizer's (PFE) cholesterol drug, Lipitor (atorvastatin calcium), entered the market ...
